Five strategies for accelerating the war on cancer in an era of budget deficits

Oncologist

Volumn 14, Issue 2, 2009, Pages 110-116

  Doroshow, James H ^a   Croyle, Robert T ^a   Niederhuber, John E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; PEMETREXED;

BUDGET; CANCER CONTROL; CANCER MORTALITY; CANCER RESEARCH; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG MECHANISM; FOOD AND DRUG ADMINISTRATION; HEALTH CARE QUALITY; HUMAN; LUNG NON SMALL CELL CANCER; MEDICARE; NATIONAL HEALTH ORGANIZATION; NOTE; OUTCOMES RESEARCH; PATIENT PARTICIPATION; PRIORITY JOURNAL; REIMBURSEMENT; TOBACCO INDUSTRY;

BUDGETS; DELIVERY OF HEALTH CARE; HEALTH SERVICES RESEARCH; HUMANS; MEDICARE; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; UNITED STATES;

EID: 63849302724     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2008-0270     Document Type: Note

References (20)

1. Unger JM, Coltman CA Jr, Crowley JJ et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol 2006;24:141-144.
2. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 2004;291:2720-2726.
3. Gross CP, Wong N, Dubin JA et al. Enrollment of older persons in cancer trials after the Medicare reimbursement policy change. Arch Intern Med 2005;165:1514-1520.
4. Grusenmeyer PA, Gralla RJ. Examining the cost and cost-effectiveness of adding bevacizumab to carboplatin and paclitaxel in advanced non-small cell lung cancer. J Clin Oncol 2006;24(suppl 18):6057.
5. Shepherd FA, Rodrigues Pereira J, Ciuleanu T et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-132.
6. Ayanian JZ, Chrischilles EA, Fletcher RH et al. Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 2004;22:2992-2996.
7. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB et al. Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:659-669.
8. National Institutes of Health (NIH). The Cancer Intervention and Surveillance Modeling Network. Modeling to Guide Public Health Research andPriorities. NIH Publication No. 09-7354. Bethesda, MD: NIH, 2008:1-51.
9. Wagner EH, Greene SM, Hart G et al. Building a research consortium of large health systems: The Cancer Research Network. J Natl Cancer Inst Monogr 2005;(35):3-11.
10. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults-United States, 2007. MMWR Morb Mortal Wkly Rep 2008;57:1221-1226.
11. Bal DG, Lloyd JC, Roeseler A et al. California as a model. J Clin Oncol 2001;19(18 suppl):69S-73S.
12. Lightwood JM, Dinno A, Glantz SA. Effect of the California tobacco control program on personal healthcare expenditures. PLoS Med 2008;5:e178.
13. Fiore MC, Croyle RT, Curry SJ et al. Preventing 3 million premature deaths and helping 5 million smokers quit: A national action plan for tobacco cessation. Am J Public Health 2004;94:205-210.
14. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. June 27, 2006. Available at http://www.surgeongeneral.gov/library/secondhandsmoke, accessed December 22, 2008.
15. U.S. Department of Health and Human Services. Treating Tobacco Use and Dependence: 2008 Update. Available at http://www.surgeongeneral.gov/tobacco, accessed December 22, 2008.
16. National Cancer Institute (NCI). The Role of the Media in Promoting and Reducing Tobacco Use. Tobacco Control Monograph No. 19. NIH Publication No. 07-6242. Bethesda, MD: NIH, 2008:51-423.
17. Shapiro JA, Seeff LC, Thompson TD et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008;17:1623-1630.
18. Vogelaar I, van Ballegooijen M, Schrag D et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 2006;107:1624-1633.
19. Klabunde CN, Lanier D, Breslau ES et al. Improving colorectal cancer screening in primary care practice: Innovative strategies and future directions. J Gen Intern Med 2007;22:1195-1205.
20. Taplin SH, Haggstrom D, Jacobs T et al. Implementing colorectal cancer screening in community health centers: Addressing cancer health disparities through a regional cancer collaborative. Med Care 2008;46(suppl 1): S74-S83.